633 related articles for article (PubMed ID: 30031397)
1. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
Sun Z; Zhao T; Lv S; Gao Y; Masters J; Weng H
J Transl Med; 2018 Jul; 16(1):209. PubMed ID: 30031397
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage After Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.
Liu J; Zhang S; Fan X; Yuan F; Dai J; Hu J
Spine (Phila Pa 1976); 2019 Jan; 44(2):E74-E81. PubMed ID: 29975331
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effects of Luteolin Against Spinal Cord Ischemia-Reperfusion Injury by Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Fu J; Sun H; Zhang Y; Xu W; Wang C; Fang Y; Zhao J
J Med Food; 2018 Jan; 21(1):13-20. PubMed ID: 28976796
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats.
Li XQ; Wang J; Fang B; Tan WF; Ma H
Mol Brain; 2014 Apr; 7():28. PubMed ID: 24751148
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis.
Gökce EC; Kahveci R; Gökce A; Cemil B; Aksoy N; Sargon MF; Kısa Ü; Erdoğan B; Güvenç Y; Alagöz F; Kahveci O
J Neurosurg Spine; 2016 Jun; 24(6):949-59. PubMed ID: 26871652
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Attenuates Spinal Cord Ischemia-reperfusion Injury in Rabbits by Decreasing Oxidation and Apoptosis.
Liu B; Liang Y; Huang W; Zhang H; Zhou D; Xiao X
Curr Mol Med; 2023; 23(6):569-577. PubMed ID: 35619277
[TBL] [Abstract][Full Text] [Related]
10. Functional protection of pentoxifylline against spinal cord ischemia/reperfusion injury in rabbits: necrosis and apoptosis effects.
Zhu DJ; Xia B; Bi Q; Zhang SJ; Qiu BS; Zhao C
Chin Med J (Engl); 2008 Dec; 121(23):2444-9. PubMed ID: 19102966
[TBL] [Abstract][Full Text] [Related]
11. Methane ameliorates spinal cord ischemia-reperfusion injury in rats: Antioxidant, anti-inflammatory and anti-apoptotic activity mediated by Nrf2 activation.
Wang L; Yao Y; He R; Meng Y; Li N; Zhang D; Xu J; Chen O; Cui J; Bian J; Zhang Y; Chen G; Deng X
Free Radic Biol Med; 2017 Feb; 103():69-86. PubMed ID: 28007572
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine postconditioning alleviates spinal cord ischemia-reperfusion injury in rats via inhibiting neutrophil infiltration, microglia activation, reactive gliosis and CXCL13/CXCR5 axis activation.
Chen F; Wang D; Jiang Y; Ma H; Li X; Wang H
Int J Neurosci; 2023 Jan; 133(1):1-12. PubMed ID: 33499703
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
14. MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway.
Li XQ; Lv HW; Wang ZL; Tan WF; Fang B; Ma H
J Neuroinflammation; 2015 Feb; 12():25. PubMed ID: 25876455
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine confers neuroprotection against transient global cerebral ischemia/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4/NF-κB pathway.
Kim E; Kim HC; Lee S; Ryu HG; Park YH; Kim JH; Lim YJ; Park HP
Neurosci Lett; 2017 May; 649():20-27. PubMed ID: 28392361
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective mechanism involved in spinal cord stimulation postconditioning.
Li H; Dong X; Cheng W; Jin M; Zheng D
J Thorac Cardiovasc Surg; 2020 Mar; 159(3):813-824.e1. PubMed ID: 31030961
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK.
Wang Z; Zhou W; Dong H; Ma X; He Z
Mol Med Rep; 2018 Oct; 18(4):3957-3964. PubMed ID: 30106098
[TBL] [Abstract][Full Text] [Related]
18. Curcumin Attenuates Inflammation, Oxidative Stress, and Ultrastructural Damage Induced by Spinal Cord Ischemia-Reperfusion Injury in Rats.
Gokce EC; Kahveci R; Gokce A; Sargon MF; Kisa U; Aksoy N; Cemil B; Erdogan B
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1196-1207. PubMed ID: 26935117
[TBL] [Abstract][Full Text] [Related]
19. Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats.
Li XQ; Lv HW; Tan WF; Fang B; Wang H; Ma H
J Neuroinflammation; 2014 Mar; 11():62. PubMed ID: 24678770
[TBL] [Abstract][Full Text] [Related]
20. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.
Bell MT; Agoston VA; Freeman KA; Puskas F; Herson PS; Mares J; Fullerton DA; Reece TB
J Vasc Surg; 2014 Apr; 59(4):1090-7. PubMed ID: 23850057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
